More misunderstanding....
No one is saying that a cannabis producer will "own" their patients. Just like the makers of advil and nurofen don't "own" me when I use their products.
The point is that the announcement states that their capacity is to produce for 6,000 patients, and people have immediately rushed and assumed that meant they are earning revenue on the full 6,000 patients.
The answer is no. Penetrating that market is hard, there are already countless cannabis products for authorised prescribers to choose from.
SAS-B applications literally only hit 38k approvals in Feb, so thinking THC will instantly be able to carve out 6,000 is naive - it will take considerable time.
- Forums
- ASX - By Stock
- EPN
- Ann: Production commenced to support 6000 Australian Patients
Ann: Production commenced to support 6000 Australian Patients, page-31
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPN (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EPN (ASX) Chart |
Day chart unavailable
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online